ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call

  Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

• How Cara Therapeutics Increased Compliance And Reduced Study Team Burden

  Delve into the partnership that helped Cara Therapeutics achieve a significant milestone in their clinical research efforts to transform the lives of chronic pruritus patients.

• How Paper And Electronic Source Data Meet ALCOA-C Principles

  According to the Food and Drug Administration (FDA), data should meet certain fundamental elements of quality. If these best practices for source documentation aren’t followed, there is no valid evidence the test article is safe and effective. 

• Using eConsent Data To Populate Site And Sponsor Data Systems

  A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.

• What The Suvoda-Greenphire Merger Means For Clinical Trials

  Simplify the clinical trial journey by unifying logistics, data, and payments. Reduce administrative friction for sites and improve the patient experience to accelerate trial timelines.

• Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study

  This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.

• Enhancing Oncology Trials With Clinical Platform Solutions

  This example involves a top 10 pharmaceutical company and explores how they were able to improve oncology trial efficiency, safety, patient experience, and more using a platform approach.

• Taking Advantage Of EMA CTR For eCOA Studies In EU

  Discover how sponsors can save time and effort by applying for clinical trial authorization once across the EU using the Clinical Trials Information System (CTIS).

• Why Oncology Drug Development Lags In Digital Biomarkers

  Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.

• Rare Disease Clinical Trials: Modern Design And Supply Chain

  Gain insight from several contributing experts for overcoming unique obstacles in rare disease research and learn how to better develop strategies.